Verastem (VSTM) EBT Growth (1y) (2012 - 2026)
Verastem (VSTM) EBT Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.10% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,140.26% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.57% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | -0.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.11% |
| Dec 31, 2025 | -28.39% |
| Sep 30, 2025 | -18.55% |
| Jun 30, 2025 | -192.70% |
| Mar 31, 2025 | -42.19% |
| Dec 31, 2024 | -7.28% |
| Sep 30, 2024 | -84.97% |
| Jun 30, 2024 | 9.16% |
| Mar 31, 2024 | -63.20% |
| Dec 31, 2023 | -76.25% |
| Sep 30, 2023 | -11.12% |
| Jun 30, 2023 | 7.59% |
| Mar 31, 2023 | -11.32% |
| Dec 31, 2022 | -1.94% |
| Sep 30, 2022 | 27.16% |
| Jun 30, 2022 | 36.87% |
| Mar 31, 2022 | 12.98% |
| Dec 31, 2021 | 16.21% |
| Sep 30, 2021 | -289.88% |
| Jun 30, 2021 | -51.16% |